GlassScriptPhysician profile
Mohamed E Ahmed
NPI 1164681201
$14,747.52
in general payments reported to CMS, 2019-2025
35 companies · $3,268 in 2025
The $3,268 reported for 2025 was more than what 76% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $705 · 2020: $2,054 · 2021: $1,321 · 2022: $3,249 · 2023: $2,932 · 2024: $1,218 · 2025: $3,268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,142 · Consulting Fee: $2,188 · Travel and Lodging: $1,989 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,141.59 |
| Consulting Fee | $2,187.50 |
| Travel and Lodging | $1,988.73 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,756.12 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Cds - Mct/Cem Monitoring |
| Abbott Laboratories | $2,156.04 | 2020-2025 | Amplatzer Amulet, Amplatzer |
| Medtronic, INC. | $755.50 | 2021-2025 | Corevalve Evolut R, Endurant Iis, Symplicity G3 |
| Amgen INC. | $695.06 | 2019-2025 | Repatha |
| Astrazeneca Pharmaceuticals LP | $658.41 | 2019-2025 | Farxiga, Brilinta |
| Abiomed | $473.96 | 2021-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $454.83 | 2019-2024 | Lifevest |
| Edwards Lifesciences Corporation | $438.99 | 2020-2024 | Pascal, Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $404.78 | 2020-2025 | |
| Shockwave Medical, INC | $318.06 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $235.02 | 2019-2023 | |
| Pfizer INC. | $168.72 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $118.31 | 2020-2024 | Xarelto |
| Amarin Pharma, INC. | $110.74 | 2019-2021 | |
| Medtronic Vascular, INC. | $108.25 | 2019-2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $91.94 | 2024-2025 | Wegovy, Ozempic |
| Angiodynamics, INC. | $85.31 | 2021-2022 | |
| Cardiovascular Systems INC. | $84.59 | 2019-2021 | |
| Esperion Therapeutics, INC. | $84.50 | 2020-2024 | Nexletol |
| Inari Medical, INC. | $81.18 | 2022-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| E.R. Squibb & Sons, L.L.C. | $70.29 | 2019-2023 | Eliquis |
| Cardiva Medical, INC. | $58.48 | 2024-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Savvywire |
| Getinge USA Sales, LLC | $50.86 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $49.06 | 2019 | |
| Veryan Medical Incorporated | $41.39 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.80 | 2024 | |
| Cordis US Corp. | $28.00 | 2023 | Rain Sheath Transradial |
| Impulse Dynamics (USA) INC. | $26.92 | 2023 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.00 | 2019 | |
| Merck Sharp & Dohme LLC | $17.43 | 2025 | Verquvo |
| Chiesi USA, INC. | $16.73 | 2024 | Kengreal |
| Teleflex LLC | $15.18 | 2022 | |
| Cardinal Health 200 LLC | $13.90 | 2020 | |
| W. L. Gore & Associates, INC. | $11.64 | 2022 | |
| Reflow Medical INC | $11.53 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohamed Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.